WEBSITE BSE:524808 NSE : PHYTOCHEM I. 18 May, 12:50
Market Cap ₹15 Cr.
Stock P/E -7.9
P/B 1.7
Current Price ₹35.6
Book Value ₹ 20.9
Face Value 10
52W High ₹55.6
Dividend Yield 0%
52W Low ₹ 29.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2 | 10 | 8 | 3 | 1 | 12 | 8 | 1 | 7 | 7 |
Other Income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 2 | 11 | 8 | 4 | 1 | 13 | 8 | 1 | 7 | 7 |
Total Expenditure | 3 | 9 | 6 | 3 | 2 | 10 | 8 | 2 | 7 | 6 |
Operating Profit | -1 | 2 | 1 | 1 | -1 | 3 | 0 | -1 | 1 | 1 |
Interest | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -1 | 1 | 1 | -0 | -1 | 2 | -0 | -2 | -0 | 0 |
Provision for Tax | -0 | 0 | 0 | -0 | 0 | -0 | 0 | -0 | -0 | -0 |
Profit After Tax | -1 | 1 | 1 | 0 | -2 | 2 | -0 | -2 | -0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
Profit After Adjustments | -1 | 1 | 1 | 0 | -2 | 2 | -0 | -2 | -0 | 0 |
Adjusted Earnings Per Share | -3.4 | 2.6 | 1.2 | 0.1 | -3.7 | 4.6 | -0.7 | -4.1 | -0.4 | 0.7 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 33 | 31 | 43 | 23 | 47 | 59 | 59 | 44 | 44 | 23 | 27 | 23 |
Other Income | 1 | 0 | 0 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
Total Income | 33 | 31 | 43 | 24 | 47 | 61 | 60 | 46 | 45 | 24 | 27 | 23 |
Total Expenditure | 31 | 28 | 40 | 22 | 44 | 57 | 57 | 42 | 42 | 22 | 24 | 23 |
Operating Profit | 3 | 3 | 3 | 2 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 1 |
Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -2 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 |
Profit After Tax | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -2 |
Adjustments | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -2 |
Adjusted Earnings Per Share | 1.5 | 1.4 | 1.3 | 0.3 | 2 | 2.1 | 1.7 | 1 | 1.1 | 0.5 | 0.5 | -4.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 17% | -15% | -14% | -2% |
Operating Profit CAGR | 0% | 0% | -6% | 0% |
PAT CAGR | 0% | 0% | -100% | -100% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -3% | 18% | 8% | 10% |
ROE Average | 2% | 3% | 4% | 6% |
ROCE Average | 8% | 8% | 8% | 10% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 10 | 10 | 10 | 11 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 4 | 2 | 3 |
Other Non-Current Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Total Current Liabilities | 17 | 22 | 26 | 19 | 31 | 45 | 60 | 53 | 30 | 24 | 25 |
Total Liabilities | 27 | 32 | 36 | 30 | 42 | 58 | 73 | 68 | 45 | 38 | 39 |
Fixed Assets | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 3 | 3 | 3 |
Other Non-Current Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Total Current Assets | 23 | 27 | 31 | 25 | 38 | 53 | 67 | 62 | 41 | 34 | 36 |
Total Assets | 27 | 32 | 36 | 30 | 42 | 58 | 73 | 68 | 45 | 38 | 39 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | -2 | -2 | -2 | -0 | 2 | 1 | 3 | 1 | -1 | 3 | 1 |
Cash Flow from Investing Activities | -1 | -1 | 0 | 1 | 0 | 0 | -1 | -0 | 1 | 0 | 0 |
Cash Flow from Financing Activities | 2 | 2 | 2 | -0 | -2 | -1 | -2 | -1 | -0 | -3 | -2 |
Net Cash Inflow / Outflow | -0 | 0 | -0 | -0 | -0 | -0 | 0 | -0 | -0 | 0 | -0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.52 | 1.43 | 1.27 | 0.25 | 1.97 | 2.14 | 1.69 | 1.04 | 1.15 | 0.53 | 0.52 |
CEPS(Rs) | 2.22 | 2.25 | 2.02 | 0.97 | 2.69 | 2.97 | 2.63 | 1.99 | 2.14 | 1.49 | 1.44 |
DPS(Rs) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 16.99 | 17.25 | 18.1 | 18.37 | 19.31 | 20.5 | 21.91 | 22.9 | 23.68 | 24.31 | 24.68 |
Core EBITDA Margin(%) | 6.21 | 8.48 | 5.43 | 5.82 | 5.34 | 3.09 | 3.49 | 3.68 | 4.96 | 6.09 | 9.72 |
EBIT Margin(%) | 6.79 | 7.3 | 5.04 | 7.26 | 5.27 | 4.8 | 4.32 | 5.55 | 5.81 | 9.92 | 8.84 |
Pre Tax Margin(%) | 2.63 | 2.66 | 1.68 | 0.66 | 2.16 | 1.73 | 1.3 | 0.81 | 1.05 | 0.85 | 0.99 |
PAT Margin (%) | 1.75 | 1.76 | 1.12 | 0.42 | 1.57 | 1.32 | 1.05 | 0.86 | 1.11 | 0.99 | 0.83 |
Cash Profit Margin (%) | 2.55 | 2.76 | 1.78 | 1.6 | 2.16 | 1.83 | 1.63 | 1.64 | 2.07 | 2.76 | 2.31 |
ROA(%) | 2.44 | 2.07 | 1.61 | 0.33 | 2.36 | 1.84 | 1.11 | 0.63 | 0.87 | 0.55 | 0.57 |
ROE(%) | 9.05 | 8.35 | 7.18 | 1.39 | 10.44 | 10.73 | 7.97 | 4.63 | 4.92 | 2.23 | 2.11 |
ROCE(%) | 14.11 | 12.5 | 10.83 | 7.93 | 11.16 | 12.33 | 10.2 | 8.99 | 8.03 | 7.25 | 7.66 |
Receivable days | 124.35 | 158.04 | 128.27 | 226.19 | 138.35 | 166.98 | 230 | 326.96 | 270.51 | 334.41 | 274.75 |
Inventory Days | 87.27 | 92.92 | 83.7 | 159.24 | 71.73 | 67.55 | 82.35 | 117.86 | 135.19 | 226.6 | 186.79 |
Payable days | 88.92 | 99.81 | 91.43 | 164.07 | 87.06 | 143.07 | 238.29 | 369.96 | 221.78 | 160.93 | 77.52 |
PER(x) | 6.71 | 7.87 | 21.07 | 118.54 | 26.75 | 27.72 | 17.16 | 17.32 | 14.91 | 37.88 | 63.46 |
Price/Book(x) | 0.6 | 0.65 | 1.48 | 1.64 | 2.72 | 2.89 | 1.32 | 0.78 | 0.72 | 0.83 | 1.33 |
Dividend Yield(%) | 9.78 | 8.89 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.48 | 0.6 | 0.63 | 1.25 | 0.87 | 0.74 | 0.58 | 0.69 | 0.64 | 1.29 | 1.25 |
EV/Core EBITDA(x) | 5.6 | 6.16 | 8.85 | 13.07 | 13.04 | 11.85 | 10.08 | 9.24 | 9.5 | 11.03 | 12.14 |
Net Sales Growth(%) | 22.35 | -6.11 | 39.3 | -46.6 | 103.96 | 25.89 | 0.02 | -25.18 | 0.6 | -48.03 | 15.75 |
EBIT Growth(%) | 12.15 | 0.39 | -3.79 | -23.15 | 49.67 | 18.12 | -10.11 | -3.7 | -10.67 | -11.25 | 3.18 |
PAT Growth(%) | -30.82 | -6.14 | -11.18 | -79.97 | 673.18 | 8.59 | -20.86 | -38.66 | 10.63 | -53.38 | -3.26 |
EPS Growth(%) | -30.82 | -6.14 | -11.19 | -79.97 | 673.19 | 8.58 | -20.86 | -38.66 | 10.63 | -53.38 | -3.25 |
Debt/Equity(x) | 1.64 | 1.92 | 2.05 | 2.02 | 2.23 | 2.1 | 2.34 | 2.33 | 2.1 | 2.03 | 1.83 |
Current Ratio(x) | 1.33 | 1.24 | 1.23 | 1.34 | 1.21 | 1.16 | 1.13 | 1.16 | 1.35 | 1.41 | 1.44 |
Quick Ratio(x) | 0.85 | 0.8 | 0.73 | 0.82 | 0.86 | 0.84 | 0.84 | 0.85 | 0.82 | 0.97 | 0.87 |
Interest Cover(x) | 1.63 | 1.57 | 1.5 | 1.1 | 1.7 | 1.57 | 1.43 | 1.17 | 1.22 | 1.09 | 1.13 |
Total Debt/Mcap(x) | 2.72 | 2.94 | 1.39 | 1.23 | 0.82 | 0.73 | 1.77 | 2.98 | 2.91 | 2.44 | 1.38 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 40.4 | 40.4 | 40.4 | 40.4 | 40.4 | 40.4 | 40.4 | 40.4 | 40.4 | 40.4 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 |
Public | 59.41 | 59.41 | 59.41 | 59.41 | 59.41 | 54.79 | 54.79 | 54.79 | 54.79 | 54.79 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Public | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About